Enlicitide: all 33 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- A Clinical Study of Enlicitide (MK-0616) in Adults With Hyperlipidemia in India (MK-0616-038)RecruitingNCT07821944Phase 3
- A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)RecruitingNCT07614984Phase 2
- A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)RecruitingNCT07058077Phase 2/3
- A Clinical Study of Enlicitide in Participants With Severe Renal Impairment (MK-0616-032)CompletedNCT06643377Phase 1Results posted
- A Clinical Study of Enlicitide Decanoate in People With Liver Function Problems (MK-0616-030)CompletedNCT06575959Phase 1Results posted
- A Study to Evaluate the Efficacy and Safety of Enlicitide (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018/CORALreef AddOn)CompletedNCT06450366Phase 3Results posted
- A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Heterozygous Familial Hypercholesterolemia (MK-0616-017/CORALreef HeFH)CompletedNCT05952869Phase 3Results posted
- A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef LipidsCompletedNCT05952856Phase 3Results posted
- Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Renal Impairment Study (MK-0616-020)CompletedNCT05934292Phase 1Results posted
- A Study of the Efficacy and Safety of Enclitide Chloride (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-008)CompletedNCT05261126Phase 2Results posted
- A Study of Enlicitide Chloride (MK-0616 Oral PCSK9 Inhibitor) in Participants With Moderate Renal Impairment (MK-0616-007)CompletedNCT05070390Phase 1Results posted
- A Clinical Trial of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-044)Active, not recruitingNCT07776665Phase 1
- A Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003)CompletedNCT07619443Phase 1
- A Clinical Study of the Effect of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-041)CompletedNCT07481708Phase 1
- A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039)CompletedNCT07300280Phase 1
- A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)Active, not recruitingNCT07216482Phase 3
- A Clinical Study of How Coffee and Tea Affect Enlicitide in Healthy Volunteers (MK-0616-040)CompletedNCT07044479Phase 1
- A Clinical Study to Evaluate Enlicitide (MK-0616) Formulations in Healthy Adult Participants (MK-0616-035)CompletedNCT06880874Phase 1
- A Single- and Multiple-Dose Study of Enlicitide Chloride (MK-0616) in Healthy Chinese Adult Participants (MK 0616-010)CompletedNCT06814106Phase 1
- A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Alendronate in Healthy Adult Participants (MK-0616-027)CompletedNCT06772792Phase 1
- A Study of Lithium and Enlicitide in Healthy Adult Participants (MK-0616-034)CompletedNCT06719544Phase 1
- A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Atorvastatin in Healthy Adult Participants (MK-0616-024)CompletedNCT06699355Phase 1
- A Study of Enlicitide Decanoate (MK-0616) and Semaglutide in Healthy Adult Participants (MK-0616-023)CompletedNCT06699329Phase 1
- A Clinical Study of Enlicitide Decanoate (MK-0616) in Healthy Adult Participants (MK-0616-025)CompletedNCT06691906Phase 1
- The Effect of Food and Water Volume in Healthy Adult Participants Administered Enlicitide Decanoate (MK-0616) (MK-0616-022)CompletedNCT06658652Phase 1
- A Study to Evaluate the Metabolism, Excretion, and Mass Balance of [¹⁴C]Enlicitide Chloride ([¹⁴C]MK-0616) in Healthy Participants (MK-0616-016)CompletedNCT06658626Phase 1
- A Study of Enlicitide Chloride (MK-0616) in Healthy Participants and Participants Taking Statins (MK-0616-012)CompletedNCT06655311Phase 1
- A Study of Levothyroxine and Enlicitide Decanoate (MK-0616) in Healthy Adult Participants (MK-0616-028)CompletedNCT06625814Phase 1
- A Clinical Study of Enlicitide and the Effect of Food in Healthy Adult Participants (MK-0616-033)CompletedNCT06609512Phase 1
- A Clinical Study to Assess the Effect of Enlicitide on How the Body Processes Digoxin in Healthy Adult Participants (MK-0616-031)CompletedNCT06597760Phase 1
- A Study of MK-0616 in Healthy Adult Participants (MK-0616-009)CompletedNCT06592339Phase 1
- Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef ExtensionActive, not recruitingNCT06492291Phase 3
- Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef OutcomesActive, not recruitingNCT06008756Phase 3